Market Cap

Taisho Pharmaceutical Holdings Co. Ltd Market Capitalization:

¥427.80 Billion

JPY as of July 1, 2023

US$2.96 Billion

business Taisho Pharmaceutical Holdings Co. Ltd Company Profile

Taisho Pharmaceutical Holdings Co. Ltd Main Stock Listing

show_chart JPX: 4581

Market Capitalization History of Taisho Pharmaceutical Holdings Co. Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $78.54 B
MERCK Kommanditgesellschaft auf Aktien $70.69 B
Takeda Pharmaceutical Company Limited $46.59 B
Haleon plc $37.99 B
Eisai Co. Ltd $17.26 B
Sector: Healthcare
Company Market Cap (USD)
UnitedHealth Group $428.70 B
Lilly $417.05 B
Johnson & Johnson $412.24 B
Novo Nordisk $329.83 B
Merck $275.82 B

Yearly evolution of Taisho Pharmaceutical Holdings Co. Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2023 ¥466.18 B -4.28%
Jan. 1, 2022 ¥487.01 B -17.86%
Jan. 1, 2021 ¥592.92 B -12.66%
Jan. 1, 2020 ¥678.86 B -28.97%
Jan. 1, 2019 ¥955.79 B 23.43%
Jan. 1, 2018 ¥774.36 B -6.30%
Jan. 1, 2017 ¥826.44 B 18.26%
Jan. 1, 2016 ¥698.83 B 7.19%
Jan. 1, 2015 ¥651.95 B 0.94%
Jan. 1, 2014 ¥645.88 B 17.91%
Jan. 1, 2013 ¥547.78 B -5.82%
Jan. 1, 2012 ¥581.64 B 10.80%
Jan. 1, 2011 ¥524.92 B 15.17%
Jan. 1, 2010 ¥455.76 B -14.50%
Jan. 1, 2009 ¥533.02 B -16.46%
Jan. 1, 2008 ¥638.06 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Taisho Pharmaceutical Holdings Co. Ltd Categories

Japan languages Healthcare languages Drug Manufacturers—Specialty & Generic
Japan Healthcare Japan Drug Manufacturers—Specialty & Generic

Stocks & Indices

Taisho Pharmaceutical Holdings Co. Ltd has the following listings and related stock indices.


Stock: JPX: 4581

Stock: OTC: TAIPY

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.